Authors: Wachtershauser, A Akoglu, B Stein, J

Citation: A. Wachtershauser et al., HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2, CARCINOGENE, 22(7), 2001, pp. 1061-1067

Authors: Gaschott, T Wachtershauser, A Steinhilber, D Stein, J

Citation: T. Gaschott et al., 1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression, BIOC BIOP R, 283(1), 2001, pp. 80-85

Authors: Wachtershauser, A Stein, J

Citation: A. Wachtershauser et J. Stein, Butyrate-induced differentiation of Caco-2 cells occurs independently fromp27, BIOC BIOP R, 281(2), 2001, pp. 295-299

Authors: Wachtershauser, A Stein, J

Citation: A. Wachtershauser et J. Stein, Rationale for the luminal provision of butyrate in intestinal diseases, EUR J NUTR, 39(4), 2000, pp. 164-171

Authors: Wachtershauser, A Loitsch, SM Stein, J

Citation: A. Wachtershauser et al., PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate., BIOC BIOP R, 272(2), 2000, pp. 380-385

Authors: Wachtershauser, A Steinhilber, D Loitsch, SM Stein, J

Citation: A. Wachtershauser et al., Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation, BIOC BIOP R, 268(3), 2000, pp. 778-783